Private Advisor Group LLC Has $1.37 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Private Advisor Group LLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,382 shares of the company’s stock after acquiring an additional 84 shares during the quarter. Private Advisor Group LLC’s holdings in HCA Healthcare were worth $1,374,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Capital World Investors increased its stake in HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares in the last quarter. Lee Danner & Bass Inc. bought a new stake in HCA Healthcare in the 2nd quarter valued at about $131,527,000. Darsana Capital Partners LP boosted its holdings in HCA Healthcare by 53.3% in the 2nd quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after purchasing an additional 400,000 shares during the period. Swedbank AB bought a new position in HCA Healthcare in the first quarter valued at $95,882,000. Finally, TD Asset Management Inc grew its holdings in shares of HCA Healthcare by 30.4% in the first quarter. TD Asset Management Inc now owns 721,318 shares of the company’s stock worth $240,581,000 after purchasing an additional 168,093 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 1.60% of the stock is owned by insiders.

HCA Healthcare Stock Down 0.7 %

Shares of HCA stock opened at $358.57 on Friday. The stock’s 50-day simple moving average is $393.62 and its 200-day simple moving average is $353.85. The firm has a market capitalization of $92.54 billion, a PE ratio of 16.10, a P/E/G ratio of 1.52 and a beta of 1.67. HCA Healthcare, Inc. has a fifty-two week low of $223.73 and a fifty-two week high of $417.14. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.85%.

Analyst Ratings Changes

A number of research firms have recently commented on HCA. Leerink Partners raised their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Royal Bank of Canada upped their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. KeyCorp reduced their price objective on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a research note on Monday. UBS Group boosted their target price on HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Finally, TD Cowen lowered their target price on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a report on Monday. Five analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $379.11.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.